These results, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 help the notion of targeting ACKR3 as a unique approach to modulate the opioid method, which could open up new therapeutic avenues for opioid-related Ailments.Gene expression Evaluation disclosed that ACKR